Skip to main content
. 2022 Jun 16;107(9):2018–2036. doi: 10.3324/haematol.2021.279513

Table 2.

Considerations regarding severe acute respiratory syndrome coronavirus-2 and second-line treatments for immune thrombocytopenia.

graphic file with name 1072018.tab2.jpg